Naltrexone Related Published Studies
Well-designed clinical trials related to Naltrexone
Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small,
randomized, double-blind, placebo-controlled, counterbalanced, crossover trial
assessing daily pain levels. [2013]
Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. [2012.01]
Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients? [2012.01]
Hepatic safety of injectable extended-release naltrexone in patients with chronic
hepatitis C and HIV infection. [2012]
The combination very low-dose naltrexone-clonidine in the management of opioid
withdrawal. [2012]
Noradrenergic vs serotonergic antidepressant with or without naltrexone for
veterans with PTSD and comorbid alcohol dependence. [2012]
Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation:
phase 2 study in rehabilitation after orthopedic surgery. [2012]
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. [2011.12.01]
Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence. [2011.10]
Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study. [2011.09.07]
Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders. [2011.09]
Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial. [2011.07.20]
Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. [2011.07]
Gabapentin combined with naltrexone for the treatment of alcohol dependence. [2011.07]
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial. [2011.07]
Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. [2011.07]
Problem drinking and low-dose naltrexone-assisted opioid detoxification. [2011.05]
Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. [2011.05]
Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. [2011.05]
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. [2011.04.30]
A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. [2011.03]
Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms. [2011.01]
The association between naltrexone treatment and symptoms of depression in opioid-dependent patients. [2011.01]
Does family history of alcoholism moderate naltrexone's effects on alcohol use? [2011.01]
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. [2011.01]
Topiramate for the treatment of alcohol dependence: comparison with naltrexone. [2011]
Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. [2011]
Characterization of abdominal pain during methylnaltrexone treatment of
opioid-induced constipation in advanced illness: a post hoc analysis of two
clinical trials. [2011]
Impact of intravenous naltrexone on intravenous morphine-induced high, drug
liking, and euphoric effects in experienced, nondependent male opioid users. [2011]
Examining naltrexone and alcohol effects in a minority population: results from
an initial human laboratory study. [2011]
Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in
patients with chronic, nonmalignant pain: a randomized controlled study. [2011]
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active
Crohn's disease: a randomized placebo-controlled trial. [2011]
Effect of subcutaneous methylnaltrexone on patient-reported constipation
symptoms. [2011]
A double-blind, placebo-controlled, randomized pilot study comparing quetiapine
with placebo, associated to naltrexone, in the treatment of alcohol-dependent
patients. [2011]
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. [2010.11.01]
Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules. [2010.11]
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. [2010.11]
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. [2010.10.01]
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. [2010.10]
A randomized trial of oral naltrexone for treating opioid-dependent offenders. [2010.09]
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010.08.21]
Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone. [2010.08.01]
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. [2010.08]
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. [2010.08]
Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain. [2010.07]
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. [2010.07]
Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. [2010.06.17]
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. [2010.06]
Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers. [2010.06]
Acute HPA axis response to naltrexone differs in female vs. male smokers. [2010.05]
ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. [2010.04]
Naltrexone implants compared to methadone: outcomes six months after prison release. [2010]
Morphine sulfate and naltrexone hydrochloride extended release capsules in
patients with chronic osteoarthritis pain. [2010]
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults
(COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3
trial. [2010]
Risk factors for craving and relapse in heroin users treated with oral or implant
naltrexone. [2010]
The effect of low-dose naltrexone on quality of life of patients with multiple
sclerosis: a randomized placebo-controlled trial. [2010]
Methylnaltrexone. [2010]
Human abuse liability assessment of oxycodone combined with ultra-low-dose
naltrexone. [2010]
ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules
in the treatment of chronic pain of osteoarthritis of the hip or knee:
pharmacokinetics, efficacy, and safety. [2010]
Acute HPA axis response to naltrexone differs in female vs. male smokers. [2010]
Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study. [2009.12.01]
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. [2009.12]
Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. [2009.11.01]
Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. [2009.11]
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. [2009.11]
Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. [2009.10]
Extended naltrexone and broad spectrum treatment or motivational enhancement therapy. [2009.10]
High-dose naltrexone therapy for cocaine-alcohol dependence. [2009.09]
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence. [2009.08.10]
Targeted naltrexone for problem drinkers. [2009.08]
Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. [2009.08]
Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. [2009.07]
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. [2009.07]
Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial. [2009.06]
Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. [2009.06]
A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. [2009.05]
A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. [2009.04.01]
Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. [2009.04]
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. [2009.04]
Early outcomes following low dose naltrexone enhancement of opioid detoxification. [2009.03]
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. [2009.03]
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. [2009.02]
A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence. [2009.01.01]
Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. [2009.01]
Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. [2009.01]
Effects of alcoholism typology on response to naltrexone in the COMBINE study. [2009.01]
Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. [2009]
Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study. [2009]
Comparing topiramate with naltrexone in the treatment of alcohol dependence. [2008.12]
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. [2008.11]
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. [2008.08.19]
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. [2008.07]
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. [2008.07]
Using topiramate or naltrexone for the treatment of alcohol-dependent patients. [2008.07]
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. [2008.07]
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. [2008.06.28]
Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? [2008.06]
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. [2008.06]
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study. [2008.06]
Methylnaltrexone for opioid-induced constipation in advanced illness. [2008.05.29]
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. [2008.05]
|
